ONTOLOGY REPORT - ANNOTATIONS
| Term: | abnormal blood cell morphology/development |
|
| Accession: | MP:0002429
|
browse the term
|
| Definition: | any structural anomaly of any of the cells found in the blood or hematopoietic organ |
| Synonyms: | exact_synonym: | blood cell abnormalities; blood cell defects |
| | alt_id: | MP:0000178; MP:0000205; MP:0001576; MP:0002545 |
|
|
abnormal CD8-positive T cell morphology
|
| Q |
Cdexp1 |
CD45RC expression in CD8 T cells QTL 1 |
|
|
IAGP |
9 |
1 |
26,311,568 |
RGD:1302824 |
RGD |
| Q |
Cdexp2 |
CD45RC expression in CD8 T cells QTL 2 |
|
|
IAGP |
20 |
3,660,638 |
10,410,227 |
RGD:1302824 |
RGD |
abnormal erythrocyte cell number
|
| G |
A2m |
alpha-2-macroglobulin |
|
|
IED |
4 |
158,103,711 |
158,153,423 |
RGD:704363 |
RGD |
abnormal hematocrit
|
| Q |
Cm6 |
Cardiac mass QTL 6 |
|
|
QTM |
7 |
47,145,774 |
107,950,815 |
RGD:727992 |
RGD |
abnormal leukocyte cell number
|
| Q |
Cm6 |
Cardiac mass QTL 6 |
|
|
QTM |
7 |
47,145,774 |
107,950,815 |
RGD:727992 |
RGD |
| Q |
Wbc1 |
White blood cell count QTL 1 |
|
|
QTM |
5 |
89,261,341 |
147,065,912 |
RGD:727992 |
RGD |
abnormal lymphopoiesis
|
| S |
WIN/RhwRrrc |
|
|
|
TAS |
|
|
|
RGD:2292495 |
RGD |
abnormal macrophage morphology
|
| G |
Gfi1 |
growth factor independent 1 transcription repressor |
|
|
IEA |
14 |
2,597,303 |
2,606,681 |
RGD:704404 |
RGD |
abnormal mononuclear cell differentiation
|
| S |
BN |
BN |
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
abnormal osteoclast differentiation
|
| S |
LEW-tl |
|
|
|
IED |
|
|
|
RGD:619693 |
RGD |
abnormal platelet dense granule number
|
| G |
Rab38 |
RAB38, member RAS oncogene family |
|
|
IAGP |
1 |
144,783,919 |
144,864,573 |
RGD:2324691 |
RGD |
| G |
Rab38ru |
Rab38, member of RAS oncogene family, ruby allele |
|
|
IAGP |
|
|
|
RGD:2324691 |
RGD |
abnormal T cell differentiation
|
| S |
WKAH.LEC-Ptprkthid/Tj |
|
|
|
TAS |
1 |
17,328,563 |
17,752,200 |
RGD:1302502 |
RGD |
anemia
|
| S |
F344-ApcPircUwm |
|
|
Onset |
IED |
|
|
|
RGD:1601201 |
RGD |
| S |
PCK/CrljCrl-Pkhd1pck/Crl |
|
|
|
TAS |
|
|
|
RGD:1580540 |
RGD |
anisopoikilocytosis
|
| G |
Hamp |
hepcidin antimicrobial peptide |
|
|
IEA |
1 |
85,978,120 |
85,980,059 |
RGD:704404 |
RGD |
decreased hemoglobin content
|
| G |
Hbb |
hemoglobin, beta |
|
|
IEA |
1 |
161,618,782 |
161,620,193 |
RGD:704404 |
RGD |
decreased leukocyte cell number
|
| Q |
Wbc3 |
White blood cell count QTL 3 |
|
Induced |
IED |
5 |
112,840,801 |
157,840,801 |
RGD:2316974 |
RGD |
| Q |
Wbc4 |
White blood cell count QTL 4 |
|
Induced |
IED |
7 |
1 |
36,741,943 |
RGD:2316974 |
RGD |
| Q |
Wbc5 |
White blood cell count QTL 5 |
|
Induced |
IED |
8 |
10,116,155 |
55,116,155 |
RGD:2316974 |
RGD |
| S |
BBDP.WF-(D8Rat59-D8Sunn1467)/Sunn |
|
|
|
IED |
8 |
112,242,639 |
128,970,675 |
RGD:1624306 |
RGD |
decreased lymphocyte cell number
|
| S |
BB/N |
|
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
| S |
BBDP/Hri |
|
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
| S |
BBDP/Rhw |
|
|
|
QTM |
|
|
|
RGD:61480 |
RGD |
| S |
BBDR.BBDP-(D4Rhw11-D4Rhw10)/Rhw |
|
|
|
TAS |
4 |
75,808,584 |
77,809,321 |
RGD:2306526 |
RGD |
| S |
BBDR.F344-(D4Arb11-D4Rat27),BBDP-(D4Rhw11-D4Rhw10)/Rhw |
|
|
|
IED |
|
|
|
RGD:2306526 |
RGD |
| S |
BBDR.F344-(D4Got33-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/Rhw |
|
|
|
IED |
|
|
|
RGD:2306526 |
RGD |
| S |
BBDR.F344-(D4Got59-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/Rhw |
|
|
|
IED |
|
|
|
RGD:2306526 |
RGD |
| S |
BBDR.F344-(D4Rat102-D4Rat27),BBDP-(D4Rhw11-D4Rhw10)/Rhw |
|
|
|
IED |
|
|
|
RGD:2306526 |
RGD |
| S |
BBDR.F344-(D4Rat102-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/1Rhw |
|
|
|
IED |
|
|
|
RGD:2306526 |
RGD |
| S |
BBDR.F344-(D4Rat102-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/2Rhw |
|
|
|
IED |
|
|
|
RGD:2306526 |
RGD |
| S |
BBDR.F344-(D4Rat102-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/3Rhw |
|
|
|
IED |
|
|
|
RGD:2306526 |
RGD |
| S |
BBDR.F344-(D4Rat153-D4Rat27),BBDP-(D4Rhw11-D4Rhw10)/Rhw |
|
|
|
IED |
|
|
|
RGD:2306526 |
RGD |
| S |
BBDR.F344-(D4Rat153-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/Rhw |
|
|
|
IED |
|
|
|
RGD:2306526 |
RGD |
| S |
BBDR.F344-(D4Rat253-D4Rat27),BBDP-(D4Rhw11-D4Rhw10)/Rhw |
|
|
|
IED |
|
|
|
RGD:2306526 |
RGD |
| S |
BBDR.F344-(D4Rat253-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/Rhw |
|
|
|
IED |
|
|
|
RGD:2306526 |
RGD |
| S |
BBDR.F344-(D4Rat26-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/Rhw |
|
|
|
IED |
|
|
|
RGD:2306526 |
RGD |
| S |
BBDR.F344-(D4Rat27-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/Rhw |
|
|
|
IED |
|
|
|
RGD:2306526 |
RGD |
| S |
BBZ |
|
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
| S |
BDIX |
|
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
| S |
LEW.Cg-Foxn1rnu/NRrrc |
|
|
|
TAS |
|
|
|
RGD:2292495 |
RGD |
decreased mast cell number
|
| G |
Hdc |
histidine decarboxylase |
|
|
IEA |
3 |
114,119,316 |
114,138,107 |
RGD:704404 |
RGD |
| G |
Kit |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
|
|
IAGP |
14 |
34,906,043 |
34,984,819 |
RGD:5133424 |
RGD |
decreased neutrophil cell number
|
| G |
Gfi1 |
growth factor independent 1 transcription repressor |
|
|
IEA |
14 |
2,597,303 |
2,606,681 |
RGD:704404 |
RGD |
decreased platelet cell number
|
| S |
WF/CrCrli |
|
|
Model |
IED |
|
|
|
RGD:1625309 |
RGD |
decreased platelet serotonin level
|
| S |
FH |
|
|
|
IED |
|
|
|
RGD:724730 |
RGD |
| S |
IR |
|
|
|
IED |
|
|
|
RGD:1004 |
RGD |
| S |
TM/Kyo |
tester moriyama rat |
|
|
IED |
|
|
|
RGD:1302447 |
RGD |
impaired hematopoiesis
|
| G |
Fos |
FBJ osteosarcoma oncogene |
|
|
IEA |
6 |
109,559,135 |
109,562,001 |
RGD:704404 |
RGD |
| G |
Gata2 |
GATA binding protein 2 |
|
|
IEA |
4 |
122,279,753 |
122,288,528 |
RGD:704404 |
RGD |
| G |
Gata3 |
GATA binding protein 3 |
|
|
IEA |
17 |
79,991,587 |
80,011,574 |
RGD:704404 |
RGD |
increased activated T cell number
|
| Q |
Ean2 |
Experimental allergic neuritis QTL 2 |
|
|
IED |
4 |
82,700,691 |
96,313,512 |
RGD:2306769 |
RGD |
| Q |
Ean4 |
Experimental allergic neuritis QTL 4 |
|
|
IED |
10 |
87,849,516 |
98,392,508 |
RGD:2306769 |
RGD |
| Q |
Ean5 |
Experimental allergic neuritis QTL 5 |
|
|
IED |
10 |
76,043,832 |
98,392,296 |
RGD:2306769 |
RGD |
increased double-negative T cell number
|
| Q |
Neudeg2 |
Neurodegradation QTL 2 |
|
|
IAGP |
5 |
25,602,274 |
45,822,846 |
RGD:1358788 |
RGD |
| Q |
Neuinf1 |
Neuroinflammation QTL 1 |
|
|
IAGP |
5 |
161,449,395 |
173,096,209 |
RGD:1358788 |
RGD |
increased eosinophil cell number
|
| Q |
Leukc1 |
Leukocyte quantity QTL 1 |
|
|
IED |
19 |
12,235,101 |
57,235,101 |
RGD:5135221 |
RGD |
| Q |
Leukc2 |
Leukocyte quantity QTL 2 |
|
|
IED |
2 |
121,545,310 |
155,102,371 |
RGD:5135221 |
RGD |
| Q |
Leukc3 |
Leukocyte quantity QTL 3 |
|
|
IED |
1 |
223,729,174 |
229,876,997 |
RGD:5135222 |
RGD |
| S |
BN.MES-Cyba/Sna |
|
|
|
IED |
|
|
|
RGD:5134976 |
RGD |
| S |
MES/Slc |
Matsumoto Eosinophilia Shinshu |
|
|
IED |
|
|
|
RGD:5134988 |
RGD |
increased erythroid progenitor cell number
|
| G |
Hbb |
hemoglobin, beta |
|
|
IEA |
1 |
161,618,782 |
161,620,193 |
RGD:704404 |
RGD |
increased hematocrit
|
| S |
F344/NHsd |
F344/NHsd |
|
|
QTM |
|
|
|
RGD:69699 |
RGD |
| S |
WKY/NCruk |
|
|
|
QTM |
|
|
|
RGD:69699 |
RGD |
increased leukocyte cell number
|
| Q |
Wbc1 |
White blood cell count QTL 1 |
|
|
IAGP |
5 |
89,261,341 |
147,065,912 |
RGD:727992 |
RGD |
| Q |
Wbc2 |
White blood cell count QTL 2 |
|
|
IAGP |
12 |
25,271,823 |
32,988,661 |
RGD:70849 |
RGD |
| S |
BDIX |
|
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
increased platelet calcium level
|
| S |
SHR.F344-(D12Mgh5-D12Mgh6)/Snk |
|
|
|
IED |
12 |
29,130,180 |
42,387,195 |
RGD:1599588 |
RGD |
increased T cell number
|
| Q |
Iddm1 |
Insulin dependent diabetes mellitus QTL 1 |
|
|
IED |
|
|
|
RGD:61075 |
RGD |
increased T cell proliferation
|
| Q |
Ean2 |
Experimental allergic neuritis QTL 2 |
|
|
IED |
4 |
82,700,691 |
96,313,512 |
RGD:2306769 |
RGD |
| Q |
Ean4 |
Experimental allergic neuritis QTL 4 |
|
|
IED |
10 |
87,849,516 |
98,392,508 |
RGD:2306769 |
RGD |
| Q |
Ean5 |
Experimental allergic neuritis QTL 5 |
|
|
IED |
10 |
76,043,832 |
98,392,296 |
RGD:2306769 |
RGD |
microcytic anemia
|
| S |
BG |
anemic Belgrade |
|
|
TAS |
|
|
|
RGD:729808 |
RGD |
microcytosis
|
| G |
Hbb |
hemoglobin, beta |
|
|
IEA |
1 |
161,618,782 |
161,620,193 |
RGD:704404 |
RGD |
Term paths to the root
|